Charles River Labs Acquires KWS BioTest

Charles River Laboratories said today it has acquired KWS BioTest for up-to-approximately £18 million (approximately $24.4 million), in a deal that will expand the discovery services offerings in oncology and immunology for this contract research organization (CRO).Based in Portishead, UK, near Bristol, UK, KWS is a CRO specializing in offering validated  in vitro  and  in vivo  models, among other discovery testing contract research services, in immuno-oncology as